This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06852/identifier/pdb/
n12http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB06852/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB06852/identifier/pubchem-substance/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06852/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB06852/identifier/chemspider/

Statements

Subject Item
n2:DB06852
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB06852 n14:DB06852
dcterms:title
4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE
adms:identifier
n6:23270845 n7:11502647 n8:99443323 n9:DB06852 n10:12C
n3:IUPAC-Name
n4:271B582C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5832-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5831-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B582E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B582F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5830-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B582A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5828-363D-11E5-9242-09173F13E4C5 n4:271B582B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5829-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5838-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5839-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5833-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5834-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5836-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5835-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5837-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B583E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5840-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5841-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B583D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B583C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B583F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B582D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B583A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B583B-363D-11E5-9242-09173F13E4C5